L04AB06 golimumab
ATC group of level 5 – chemical substance · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases
This site has the patient leaflet or the SPC of 9 medicines in this group.
- 8 prescription only (POM)
Active substance: Golimumab – all medicines with this substance, also in combinations.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,815 medicines
- L04 Immunosuppressants 565 medicines
- L04A Immunosuppressants 563 medicines
- L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors 76 medicines
- L04AB06 golimumab 9 medicines
- L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors 76 medicines
- L04A Immunosuppressants 563 medicines
- L04 Immunosuppressants 565 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Gobivaz 100 mg solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Gobivaz 100 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Gobivaz 50 mg solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Gobivaz 50 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| GOTENFIA 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE SPC | – |
| Simponi 100 mg solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Simponi 45 mg / 0.45 ml solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Simponi 50 mg solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Simponi 50 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
Other groups of the same level
- L04AB01 etanercept 15 medicines
- L04AB02 infliximab 7 medicines
- L04AB04 adalimumab 42 medicines
- L04AB05 certolizumab pegol 3 medicines
Other names of the ATC group
- Czech: L04AB06 Golimumab
- French: L04AB06 golimumab
- German: L04AB06 Golimumab
- Spanish: L04AB06 Golimumab
- German: L04AB06 Golimumab
- Italian: L04AB06 Golimumab
- Polish: L04AB06 Golimumab
- Turkish: L04AB06 golimumab
- Portuguese (Brazil): L04AB06 Golimumab
- German (Switzerland): L04AB06 Golimumab
- French (Switzerland): L04AB06 Golimumab
- Italian (Switzerland): L04AB06 Golimumab
- English (Canada): L04AB06 Golimumab
- French (Canada): L04AB06 Golimumab
- Slovak: L04AB06 Golimumab
- Dutch: L04AB06 Golimumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L04AB06
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
